ABOUT RADISENS

ABOUT RADISENS

Measure Ferritin with Gemini™

Radisens is developing a high sensitivity, quantitative point-of-care (PoC) in-vitro diagnostics platform – Gemini™ – to measure ferritin (iron stores) as a screen for iron deficiency. The platform uses a fingerstick blood sample, and comprises a ferritin test cartridge with an accompanying reader to match laboratory analyser performance.

Ferritin declines early in the development of iron deficiency, before the decline of haemoglobin; hence its value as a screening test to identify those with low iron stores or who also may be at risk of becoming anaemic.

Screening for iron deficiency

The current clinical uses for ferritin are restricted to laboratory testing but there are several applications for a quantitative measurement of ferritin at PoC which would allow for immediate clinical intervention. Iron deficiency is prevalent amongst blood donors, maternal health (during & after pregnancy), in paediatrics, adolescents and athletes.

Grant-aided FerrTest

Radisens Diagnostics is leading a €6 million grant-aided FerrTest consortium, including Trinity College Dublin, Irish Manufacturing Research and PolyPico Technologies. The project will complete product & process development and scale-up ahead of pre-clinical trials. Radisens seeks partner(s) to complete funding of this development and support commercialisation of the Gemini™ ferritin test.

MEET THE TEAM

MEDICAL ADVISORY BOARD